Cite

HARVARD Citation

    Berlanga, P. et al. (2021). Central nervous system relapse in high-risk stage 4 neuroblastoma: The HR-NBL1/SIOPEN trial experience. European journal of cancer. pp. 1-8. [Online]. 
  
Back to record